A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection
This study has been terminated.
(Study terminated due to an unexpected prominent effect of entecavir alone in this patient population.)
First Posted: October 8, 2010
Last Update Posted: August 16, 2016
Information provided by (Responsible Party):